Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Coronary disease: a new perspective thanks to ultrasound

05.06.2008
Combat atherosclerosis more effectively with powerful statins

Compared to other techniques, Intravascular Ultrasound (IVUS) is much better at monitoring the increase or decrease of atherosclerosis in the coronary arteries. Can the method even be used to predict the odds of a heart attack or other cardiovascular event?

Studies indicate this may be the case, states Professor Clemens von Birgelen in his inaugural address at the University of Twente. Results of IVUS measurements also raise the question of whether patients with demonstrated coronary disease should be treated with more powerful cholesterol-lowering statins to reverse atherosclerosis. Von Birgelen's inaugural address takes place on 5 June.

Narrowed coronary arteries due to atherosclerosis can be visualised using 'classic' cardiac catheterisation, but the technique only shows the space the blood flows through, the 'lumen', and not the diseased vascular wall surrounding it. By using a specialised catheter with an ultrasound 'sensor', IVUS also creates images of the calcifications, the ‘plaque’, and allows various components of the plaque to be identified – not only calcium, but also fat and connective tissue.

Von Birgelen states that this additional information is important for assessing disease progression - plaque progression. Plaque initially leaves the lumen unaffected and grows outward. The blood vessel as a whole becomes wider, leading to a significantly increased risk of heart attack. However, plaques may also decrease in volume while the lumen diameter remains the same, something that can only be determined using IVUS.

Statins

Various studies have shown a relationship between plaque growth and cardiovascular events, such as heart attacks. “Plaque progression measured using IVUS could become a valuable 'surrogate marker' for cardiovascular events”, states Von Birgelen. In his address, he also highlights the relationship between plaque progression and cholesterol. Decreasing cholesterol through intensive statin therapy not only slows plaque formation, but actually reverses it. This is reason enough for the professor to question the current target value for LDL cholesterol of 2.5 for patients with coronary disease; at that value, over half of patients still have plaque growth. Von Birgelen wants to determine whether or not a large group of patients is receiving sub-optimal treatment for reducing plaque.

Drug eluting stents

IVUS also plays an important role in the treatment of narrow coronary arteries, for example during balloon dilation and the placement of a so-called 'stent'. New types of stents are being made with integrated regulated drug release to prevent the formation of scar tissue in the stent – thereby decreasing the odds of recurrence. Von Birgelen is currently performing research on these new stents at the University of Twente, and will soon be launching the so-called 'TWENTE study' at the Medisch Spectrum Twente hospital, in which about 1400 patients will be treated with one of two promising drug eluting stents in order to compare the clinical results. “During some PCI procedures, IVUS is essential for properly guiding the implantation”, according to Von Birgelen. He believes that good invasive imaging of the coronary arteries will remain important in future in order to safeguard the quality of care for heart patients.

Professor Clemens von Birgelen is a cardiologist on staff at the Thorax Centre of the Medisch Spectrum Twente in Enschede. His Chair at the University of Twente, made possible in part by the Heart Centre Twente Foundation and entrepreneur Ferdinand Fransen, shares the university's ambition to play a leading role in the development and application of technology in healthcare.

Wiebe van der Veen | alfa
Further information:
http://www.utwente.nl

More articles from Medical Engineering:

nachricht New bioimaging technique is fast and economical
21.08.2017 | Rensselaer Polytechnic Institute

nachricht Noninvasive eye scan could detect key signs of Alzheimer's years before patients show symptoms
18.08.2017 | Cedars-Sinai Medical Center

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Nagoya physicists resolve long-standing mystery of structure-less transition

21.08.2017 | Materials Sciences

Chronic stress induces fatal organ dysfunctions via a new neural circuit

21.08.2017 | Health and Medicine

Scientists from the MSU studied new liquid-crystalline photochrom

21.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>